SR (60mg)gliclazide,SR (500 mg)Metformin

Jun 20, 2023

gliclazide SR (60mg),Metformin SR (500 mg)
GLICLAGLAZE MET
Gliclazide SR (sustained-release) and Metformin SR (sustained-release) are both medications used in the treatment of type 2 diabetes.  Gliclazide is an oral anti-diabetic medication from the sulfonylurea class. It helps to lower blood sugar levels by stimulating the release of insulin from the pancreas. The "SR" designation indicates that it is a sustained-release formulation, which means that the medication is released slowly over time, providing a prolonged effect. The dosage you mentioned, 60 mg, indicates that each tablet contains 60 milligrams of gliclazide.
 Metformin is an oral anti-diabetic drug from the biguanide class. It works by reducing the production of glucose by the liver and improving insulin sensitivity in the body. The "SR" designation also indicates that it is a sustained-release formulation. In this case, each tablet contains 500 milligrams of metformin.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/gliclaglaze-met-133421

SHARE WITH